Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Eli Lilly and Company

Eli Lilly and Company (LLY.TO) Stock Overview

Explore Eli Lilly and Company’s financial performance, market position, analyst ratings, and future outlook.

LLY.TO●TSX
HealthcareMedical - Pharmaceuticals
$42.80
$0.29(0.68%)
Canadian Market opens in 24h 28m

Eli Lilly and Company (LLY.TO)

Meyka AI Score

Z

Key Financials

Market Cap1.5T
P/E RatioN/A
EPS (TTM)$1.09
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Month$50.19
3 Months$42.08
1 Year Target$44.44

LLY.TO Stock Analysis & Investment Overview (TSX)

Our AI-powered analysis of Eli Lilly and Company (TSX: LLY.TO) gives investors deep insight into how the stock performs on the TSX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Eli Lilly and Company's TSX-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of LLY.TO on the TSX shows an RSI of 56.25, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $44.44 for the TSX listing.

Key metrics behind Eli Lilly and Company's TSX-traded stock include a P/E ratio of N/A and a market capitalization of 1.5T. Combined with our AI analysis, these give both institutional and retail investors a clear view of LLY.TO on the TSX.

Price Performance (TSX: LLY.TO)

1-Day Change
0.68%
5-Day Change
3.13%
1-Month Change
6.71%
3-Month Change
34.17%
6-Month Change
11.02%
Year-to-Date (YTD) Change
9.52%
1-Year Change
9.52%
3-Year Change
9.52%
5-Year Change
9.52%
All-Time (Max) Change
9.52%

Contact Information

https://www.lilly.com
NaN
P.O. Box 73, Exchange Tower 130 King Street West, Suite 900, Indianapolis, IN, M5X 1B1

Company Facts

500,000 Employees
IPO DateDec 22, 2025
CountryUS
Actively Trading

Frequently Asked Questions